The potential in emerging markets have been growing in the last years. The key to its success is having know how which is gained by having experience. Due to complex legislation and regulations changes in this rapidly growing market consulting is essential for any company wanting to succeed in a certain country. At Empharma we combine local experitse with our business savy international thinking to offer our clients a range of fully customizable consulting solutions to fulfill their needs.

International companies looking to enter emerging markets are often frustrated by market data that’s incomplete, unreliable or contradictory – or simply unavailable.Empharma draws on its deep knowledge of local markets, extensive personal networks and proprietary knowledge database to offer clear, accurate, reliable information, enabling rapid and effective action plans that delivers results.

Good strategic advice is cruicial in emerging markets. Yet few global consulting firms have experience or expertise in the pharmaceuticals industry. Our years worth experience guide us to comprehend our clients needs and wants in order for us offer them a solution that is reliable and achievable. We can advise across a wide range of strategic and operational issues, across multiple nations.

Market access tools can be highly effective in increasing sales of a product in both the reimbursement and commercial sectorsOur experience in communications with leading doctors, government officials, decision-makers and influencers enables us to quickly share information with target audiences as well as guide or partners on all stages gone through a new or existing product from the formulation to the sales

Full-scale marketing campaigns. Comprehensive campaigns targeted at multiple parties promoting anything from a product to a large portfolio

Stand-alone events. Including advisory boards or doctors for specific products, scientific symposia at relevant events, launch conferences, educational campaigns and training initiatives

Including features in trade and general press, involvement of opinion leaders, and targeted communications to patients and civil advocacy groups

• Registration of new medicines and medical devices
• Completion of pending regulatory submissions